SBC Medical Group Holdings Business Summary

SBC Medical Group Holdings Inc. (SBC) operates a comprehensive franchise-based business model providing management and consulting services to a global network of aesthetic medical clinics. The company generates revenue through five primary segments: Franchising (royalty fees for intellectual property), Procurement (resale of medical consumables and equipment), Management Services (advertising, marketing, and recruitment), Rental (facility and equipment leasing), and Other services. As of February 2026, SBC maintains a dominant position in the Japanese aesthetic medicine market with an estimated 25% share across over 250 franchise locations, while aggressively expanding into the U.S., Singapore, Thailand, and Vietnam. In the competitive landscape of healthcare services and specialized medical management, SBC competes with firms such as Addus HomeCare, Surgery Partners, and Fortrea, distinguishing itself through a high-margin, asset-light franchise model and a specialized focus on cosmetic dermatology and plastic surgery. The company is led by its founder, Dr. Yoshiyuki Aikawa, who serves as Chairman and CEO and holds a medical degree from Nihon University with extensive experience in aesthetic plastic surgery. The executive team features high-pedigree leadership, including Yuya Yoshida (CFO, COO, and Chief AI Ambassador), formerly of Rakuten Group and Mitsubishi UFJ Financial Group; Miki Shimizu (Chief Strategy Officer), a former Investment Banking Director at Goldman Sachs; and Kazuki Ichimori (Chief Corporate Development Officer), who previously led major fundraising rounds at SmartNews. The board includes independent directors such as Fumitoshi Fujiwara and Ken Edahiro, bringing expertise from private equity and digital marketing. Notable institutional backing includes positions from Geode Capital Management, Millennium Management, and SBI Securities, supporting the company's recent strategic pivot toward AI-driven clinical operations and international M&A, including its 2026 alliance with the U.S.-based MedSpa platform OrangeTwist.